这个公司也没有几个临床试验产品, 而且这个特发性肺纤维化也不是很常见的疾病, $40/share is really hing Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating and ultimately fatal disease that affects approximately 200,000 people in Europe and the United States combined, with approximately 30,000 new cases reported per year in each region.